Diseases, Conditions, Syndromes

Pfizer/BioNTech first dose 85% effective after 2-4 weeks: study

The first dose of the Pfizer/BioNTech vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal.

Vaccination

South Africa offers AstraZeneca jabs to AU

South Africa said Tuesday it would offer its doses of Oxford/AstraZeneca COVID vaccine to the African Union (AU) after scrapping their use due to efficacy concerns.

Diseases, Conditions, Syndromes

Vaccine hoarding to delay Africa's COVID-19 recovery

Controlling the spread of COVID-19 is perhaps the most critical public health concern globally today but the rush for its vaccine doses in bilateral deals by the developed world could delay Africa's recovery from the disease.

Vaccination

AstraZeneca files vaccine for approval in Japan

AstraZeneca said Friday it has filed for approval of its coronavirus vaccine in Japan, becoming the second major pharmaceutical firm to ask Tokyo to authorise its jabs.

page 2 from 35